Indian Journal of Critical Care Medicine

Register      Login



Volume / Issue

Online First

Related articles

VOLUME 15 , ISSUE 3 ( July, 2011 ) > List of Articles


Neurocysticercosis: Acute presentation and intensive care management of two cases

Lokesh Kumar, Girija Rath, Aanchal Sharma, Sarita Mohapatra, Uma P. Padhy

Keywords : Cerebral edema, intensive care management, intracranial pressure, neurocysticercosis, seizures

Citation Information : Kumar L, Rath G, Sharma A, Mohapatra S, Padhy UP. Neurocysticercosis: Acute presentation and intensive care management of two cases. Indian J Crit Care Med 2011; 15 (3):185-187.

DOI: 10.4103/0972-5229.84899

License: CC BY-ND 3.0

Published Online: 01-06-2018

Copyright Statement:  Copyright © 2011; The Author(s).


Neurocysticercosis (NCC), a common helminthic infestation in developing countries, may cause acquired epilepsy and neurological morbidities. Acute symptomatic seizure is the most common manifestation. The other clinical conditions include headache, hydrocephalus, chronic meningitis, focal neurological deficits, and psychological disorders. Altered sensorium and raised intracranial pressure (ICP) may require ventilatory support in an intensive care unit (ICU). Definitive diagnosis is made by identification of parasites in tissues or by a radiological demonstration of the scolex in cystic lesions. Antiepileptic drugs are used to control seizures after NCC. Steroids are generally administered along with antihelminthics, in order to control the edema and intracranial hypertension that may occur as a result of antiparasitic medications. In patients with intracranial hypertension, the priority is to manage the ICP before considering other treatment options. Antiparasitic drug treatment is never the mainstay of treatment, especially in the setting of elevated ICP. Here, we present the ICU management of two such cases.

PDF Share
  1. Prasad KN, Prasad A, Verma A, Singh AK. Human cysticercosis and Indian scenario: A review. J Biosci 2008;33:571-82.
  2. Garcia HH, Gonzalez AE, Evans CA, Gilman RH. Cysticerosis Working Group in Peru. Taenia solium cysticercosis. Lancet 2003;362:547-56.
  3. Roman G, Sotelo J, Del Brutto O, Flisser A, Dumas M, Botero D, et al. A proposal to declare neurocysticercosis an international reportable disease. Bull World Health Organ 2000;78:399-406.
  4. Chadha V, Pandey PK, Chauhan D, Das S. Simultaneous intraocular and bilateral extraocular muscle involvement in a case of disseminated cysticercosis. Int Ophthalmol 2005;26:35-7.
  5. Llompart Pou JA, Gene A, Ayestaran JI, Saus C. Neurocysticercosis presenting as sudden death. Acta Neurochir (Wien) 2005;147:785-6.
  6. García HH, Evans CA, Nash TE, Takayanagui OM, White AC Jr, Botero D, et al.. Current consensus guidelines for treatment of neurocysticercosis. Clin Microbiol Rev 2002;5:747-56.
  7. Rajshekhar V. Surgical management of neurocysticercosis. Int J Surg 2010;8:100-4.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.